Back

Early and late changes in right heart echocardiographic parameters in hypertrophic cardiomyopathy patients after transvenous cardiac device implantation.

30 August 2025 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: Hypertrophic cardiomyopathy (2) Hypertrophic Cardiomyopathy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Miss Caitlin Grealy

St Bartholomew's Hospital, London (United Kingdom of Great Britain & Northern Ireland)

3 More presentations in this session

Presentation thumbnail
Associated phenotypes of pathogenic CACNA1C variants in a large cohort of patients undergoing genetic testing
Doctor M. Brogger (A Coruna, ES)
Abstract Slides Video
Presentation thumbnail
Electrocardiographic markers of left ventricular hypertrophy indicate response to mavacamten in hypertrophic obstructive cardiomyopathy
Doctor F. Buehning (Essen, DE)
Abstract Slides Video
Presentation thumbnail
Overcoming sudden cardiac death and heading towards progressive heart failure: Insights from a hypertrophic cardiomyopathy referral-center cohort
Doctor A. Papageorgiou (Athens, GR)
Abstract Slides Video

Access the full session

Session thumbnail
Hypertrophic cardiomyopathy (2)

The Event

Event poster

ESC Congress 2025

30 August 2025 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Occurrence and long-term outcomes of pacing-induced cardiomyopathy in a large leadless pacemaker cohort
thumbnail
Congress Presentation
Assessment of changes in right-sided cardiac echocardiographic parameters in obstructive hypertrophic cardiomyopathy during mavacamten treatment
thumbnail
Congress Presentation
Similar incidence of PICM in patients with preserved and moderate range ejection fraction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources